摘要
目的建立高效液相色谱法测定血浆中替考拉宁(TEIC)总浓度(Ct)和游离浓度(Cf)的方法。方法游离浓度血浆样本经超滤离心管处理后进行HPLC分析。采用C1g色谱柱,以乙腈0.01·mL^-1磷酸二氢钠(25:75,磷酸调pH值至3.3)为流动相,检测波长240 nm,柱温35 C,流速1.0 mL·mL^-1,考察该方法的专属性、标准曲线、定量下限、精密度、回收率和稳定性。结果游离浓度在0.5~50μg·mL^-1内线性关系良好(y=12801x-2574.1,r^2=0.9998),定量下限为0.5μg·mL^-1,方法回收率为94.63%~103.72%,批内、批间RSD均<4.00%;总质量浓度在1.5625~100μg·mL^-1内线性关系良好(y=10576:x+9950.1,r^2=0.9998),定量下限为1.5625μg·mL^-1,方法回收率为94.55%~99.59%,批内、批间RSD均<4.00%。在室温放置10h、冻融循环3次和4℃冷藏72 h稳定性良好。结论本方法简便、准确、灵敏,适用于临床替考拉宁血药总浓度和游离浓度的检测及药动学的研究。
OBJECTIVE To establish an HPLC method for the determination of total(Ct)and free(Cf)concentrations of teico-planin(TEIC)in plasma.METHODS For determing the free concentration,the plasma samples were prepared by ulrafiltration.A Cx colunn was used,with acetonitrile-0.01·mL^-1sodium dihydrogen phosphate(25:75,pH adjusted to 3.3 by phosphoric acid)as the mobile phase,the detection wavelength was set at 240 nm,the column temperature was maintained at 35 C,and the flow rate was 1.0·mL^-1.The speificity,linearity,the lower limit of quantitation,precession.recovery and stability of the developed meth-od were validated.RESULTS The free concentration was linear with in 0.5-50μg·mL^-1,the lower limit of quantification was 0.5μg·mL^-1,and the method recovery rate was 94.63%-103.72%。The intra-day and inter-day precision(RSD)were all less than 4.00%;the linearity was good with in the total concentration of 1.5625-100μg·mL^-1,the lower limit of quantification was 1.5625μg·mL^-1,the method reeovery rale was 94.55%-99.59%.The intra-day and inter day precision(RSD)were all less than 4.00%。The TEIC was all stability at the conditions of maintaining at room temperature for 10 h,after freeze-thaw cycle and keeping at 4℃ for 72 h.CONCLUSION The method is simple,accurate,and sensitive,and is suitable for the clinical determination of total and free concentrations of teicoplanin and the studly of pharmacokinetis.
作者
张素平
王海平
修连喜
黄巧妹
梁桂荣
张忠诚
阮天福
ZHANG Su-ping;WANG Hai-ping;XIU Lian-xi;HUANG Qiao-mei;LIANG Gui-rong;ZHANG Zhong-cheng;RUAN Tian-fu(The Second Hospilal of longyan,Longyun 364000,China;The Graduale School of Flujian Medical University,Fuzhou 350122,China)
出处
《中国药学杂志》
CAS
CSCD
北大核心
2020年第15期1284-1288,共5页
Chinese Pharmaceutical Journal
基金
龙岩市科技计划立项资助(2017LY66)。